Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT00151177

Continuous Positive Airway Pressure Ventilation After Acute Ischemic Stroke

Feasibility and Efficacy Study of Early Continuous Positive Airway Pressure Ventilation in Patients With Acute Ischemic Stroke

Sponsor: New Health Sciences, Inc.

Conditions Brain Infarction

Interventions CPAP-treatment non-invasive continuous positive airway pressure ventilation

Updated 6 times since 2017 Last updated: Nov 23, 2010 Started: Apr 30, 2005 Primary completion: Jan 31, 2008 Completion: Apr 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Brain Infarction, this trial is completed. The trial is conducted by New Health Sciences, Inc. and has accumulated 6 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE1/PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Apr 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

New Health Sciences, Inc.
Rubel GmbH, Heiligenhaus, Germany
University Hospital Muenster

Data source: University Hospital Muenster

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Münster, Germany